| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.74B | 50.45B | 46.52B | 59.82B | 54.11B | 48.16B |
| Gross Profit | 5.08B | 4.99B | 4.67B | 5.80B | 5.08B | 4.32B |
| EBITDA | 5.30B | 5.27B | 4.73B | 5.66B | 4.92B | 4.28B |
| Net Income | 2.26B | 2.19B | 2.05B | 2.70B | 2.26B | 1.75B |
Balance Sheet | ||||||
| Total Assets | 51.13B | 51.11B | 49.50B | 44.44B | 41.99B | 42.54B |
| Cash, Cash Equivalents and Short-Term Investments | 9.71B | 9.46B | 9.42B | 9.31B | 7.10B | 5.94B |
| Total Debt | 8.26B | 8.58B | 9.10B | 9.66B | 10.42B | 12.30B |
| Total Liabilities | 20.67B | 20.84B | 21.26B | 19.98B | 20.49B | 22.87B |
| Stockholders Equity | 30.45B | 30.26B | 28.23B | 24.46B | 21.49B | 19.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.12B | 1.41B | 3.36B | 3.52B | 2.90B |
| Operating Cash Flow | 0.00 | 3.80B | 3.91B | 5.24B | 4.52B | 3.69B |
| Investing Cash Flow | 0.00 | -2.83B | -2.67B | -2.01B | -784.00M | -612.00M |
| Financing Cash Flow | 0.00 | -1.26B | -1.38B | -1.23B | -2.45B | -1.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥19.18B | 6.27 | ― | 2.46% | 7.13% | 16.09% | |
74 Outperform | ¥156.58B | 9.98 | ― | 3.65% | 7.73% | -19.90% | |
68 Neutral | ¥76.54B | 9.20 | ― | 3.63% | 2.67% | 18.02% | |
67 Neutral | ¥310.21B | 19.07 | ― | 2.94% | 4.50% | 82.34% | |
66 Neutral | ¥305.11B | 12.68 | 8.30% | 2.50% | 7.94% | -13.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥315.29B | 20.24 | ― | 1.28% | 8.11% | -9.27% |